Miriam MERAD

Miriam Merad, M.D.; Ph.D. is the Chair of the Department of Immunology and Immunotherapy,Director of the Precision Immunology Institute at Mount Sinai School of Medicine in New York and theDirector of the Mount Sinai Human Immune Monitoring Center (HIMC).

Dr. Merad is an internationally acclaimed physician-scientist and a leader in the fields of dendritic celland macrophage biology with a focus on their contribution to human diseases. Dr. Merad identifiedthe tissue-resident macrophage lineage and revealedits distinct role in organ physiology andpathophysiology. She established the contribution of this macrophage lineage to cancer progressionand inflammatory diseases and is now working on developing novel macrophage-targeted therapiesfor these conditions. In addition to her work on macrophages, Dr. Merad is known for her work ondendritic cells, which control adaptive immunity. She identified a new subset of dendritic cells, nowconsidered a key antiviral and antitumor immunity target.

Dr. Merad leads the Precision Immunology Institute at the Icahn School of Medicine (PrIISM) to bringimmunology discoveries to the clinic. PrIISM integrates immunological research programs withsynergistic expertise in biology, medicine, technology, physics, mathematics, and computationalbiology to enhance our understanding of human immunology. She also founded the Human ImmuneMonitoring Center at Mount Sinai, one of the world’s most sophisticated research centers, which usescutting-edge single-cell technology to understand the contribution of immune cells to major humandiseases or treatment responses.

Dr. Merad has authored more than 200 primary papers and reviews in high-profile journals. Her workhas been cited several thousand times. She receives generous funding from the National Institutes ofHealth (NIH) for her research on innate immunity and its contribution to human disease and belongsto several NIH consortia. She is an elected member of the American Society of Clinical Investigationand the recipient of the William B. Coley Award for Distinguished Research in Basic and TumorImmunology. She is the President of the International Union of Immunological Societies (IUIS). In 2020,she was elected to the National Academy of Sciences in recognition of her contributions to the field ofimmunology.